gynecology.hospital

Female Genital Cutting

Female circumcision, clinically FGM/C, affects ~230 million women and girls, 144 million of them in Africa. Prevalence is near-universal in Somalia and Guinea, falling in Kenya and Burkina Faso. Education, community dialogue and enforced law help; paying cutters does not.

gynecology.hospital Editorial TeamEditorial briefing13 min read
Female Genital Cutting

Female Circumcision in Africa:
Where It Still Holds, and What Three Decades of Work Actually Changed

High-prevalence states, high-burden populations, medicalization, and the gap between programme reports and the 2030 target

The phrase most families still use is “female circumcision.” The phrase clinics, courts and UN agencies use is female genital mutilation, or FGM/C. The gap between those two names is not a quarrel about manners. It is the reason a procedure with no medical indication still happens to millions of girls, often before they can speak for themselves, and why a doctor in Khartoum or Cairo can convince herself she is reducing harm by doing it in a clinic.

More than 230 million girls and women alive today have undergone some form of the practice. About 144 million of them live in Africa. Another 4.4 to 4.5 million girls are estimated to be at risk in 2026, more than half of them younger than five. Those totals have risen even as prevalence has fallen in a string of countries, because the populations that practise FGM are young and growing. UNICEF’s 2024 revision added 30 million survivors to the earlier 200-million estimate — partly better counting, partly demography.

This article is written for clinicians and editors who need the map, not the slogan. It separates high-prevalence countries from high-burden countries, sets out what the evidence says has moved the needle, and names the interventions that have been tested and found not to work.

What is being done to the body

WHO classifies four types. Type I is partial or total removal of the clitoral glans and/or the prepuce. Type II adds the labia minora, with or without the labia majora. Type III — infibulation — narrows the vaginal opening by cutting and repositioning the labia into a covering seal, sometimes with stitching, leaving a small aperture for urine and menses. Type IV covers every other non-medical injury: pricking, piercing, incising, scraping, cauterizing.

Infibulation is the minority of cases globally, about 15 percent, and the majority of the obstetric disaster. A woman with Type III often needs deinfibulation before intercourse or labour. Re-infibulation after birth — stitching her closed again — is still requested in some settings and is itself a further injury. Types I and II dominate in West Africa. Type III is concentrated in the Horn and parts of Sudan and Egypt’s older cohorts. Severity has not fallen as fast as prevalence. Koski and Heymann’s 30-year comparison of 22 countries found cutting becoming less common in most of them, but little national-scale shift toward milder procedures.

There is no health benefit. Immediate harms are haemorrhage, shock, acute infection including tetanus, urinary retention, injury to adjacent tissue, and death. Later come recurrent UTI, dysmenorrhea and haematocolpos behind a tight seal, cysts and keloid, apareunia and dyspareunia, depression, anxiety and PTSD. In labour: prolonged second stage, tears, postpartum haemorrhage, fistula in the worst obstructed cases, and a higher risk of stillbirth and early neonatal death. WHO estimates that treating the complications already costs health systems about US$1.4 billion a year.

High prevalence is not the same as high burden

A national percentage and a headcount tell different stories. Somalia, Guinea and Djibouti sit at the top of the prevalence table — on the order of 99, 95 and 90 percent of women aged 15 to 49. Mali is around 89 percent, Egypt and Sudan around 87, Sierra Leone and Eritrea around 83, the Gambia around 73. Those figures come from the latest nationally representative DHS and MICS rounds compiled by UNICEF. They describe how normal the practice is inside a given society.

Burden is a different number. Ethiopia, at roughly 65 percent prevalence, is home to about 30 million affected girls and women — the largest absolute population in Eastern and Southern Africa. Egypt’s percentage is high and its population is large; Sudan’s war has pushed practising communities across borders. Nigeria’s national rate is only about 15 percent, but the denominator is so big that the country still contributes a substantial share of West Africa’s 49 million affected women. Kenya fell from 32 percent in 2003 to 15 percent in 2022 and still has about three million survivors.

The clinical implication is crude and useful. A gynaecologist planning fistula or deinfibulation services cannot look only at the red countries on a prevalence map. She has to look at where the women are.

Selected African prevalence among women 15–49 (UNICEF compiled DHS/MICS; survey year varies)

Country

Approx. prevalence

Why it matters

Somalia

~99%

Near-universal; little 30-year decline

Guinea

~95%

Stuck at the top of West Africa

Djibouti / Mali

~90% / ~89%

Social norm still majority practice

Egypt / Sudan

~87% / ~87%

Medicalization capital of the practice

Sierra Leone / Eritrea

~83% / ~83%

Eritrea now cited as on an elimination path

Gambia

~73%

2015 ban nearly repealed in 2024

Ethiopia

~65%

~30 million affected; largest ESA caseload

Burkina Faso

~56% (15–19: 32%)

Law plus enforcement; real cohort drop

Kenya

~15% (was 32% in 2003)

National drop hides Somali-county rates near 90%+

Uganda

<1%

On track for 2030 elimination nationally

The countries that remain stuck — and the ones that moved

Somalia is the hard case. UNICEF’s Eastern and Southern Africa profile treats it as the regional exception: communities elsewhere are shifting, Somalia is not. Cutting there is commonly done between ages five and nine, marriageability is still tied to it, and federal criminal law has lagged. Galmudug passed an anti-FGM law in 2024 and Jubaland in 2025. That is progress on paper in a fragmented state. It is not yet a prevalence curve.

Guinea, Mali and the Gambia have spent decades near the ceiling. In Guinea and Mali the national rate among 15-to-49-year-olds has barely blinked. Mali still records about 73 percent prevalence among girls aged 0 to 14 — a warning that the next cohort is not being spared. The Gambia is the political warning. A 2015 ban produced the first convictions; a private member’s bill in 2024 tried to take the ban off the books and almost succeeded. Parliament rejected the clauses in July 2024 after doctors and survivors testified. A Supreme Court challenge was still listed into 2025. A law that can be walked back after nine years is not a settled norm.

Egypt and Sudan are the medicalization story. In the Arab States cluster that includes them, most cutting in Egypt and Sudan is now done by doctors or midwives — UNICEF has put medicalization at about 82 percent in Egypt and 77 percent in Sudan. Families buy the white coat as a safety feature. WHO’s position is the opposite: a health worker who cuts is not reducing FGM, she is laundering it. The 2025 WHO guideline on prevention and clinical management was written in part to stop that drift and to standardise deinfibulation, mental-health care and sexual-function interventions for women already living with the scar.

Then there are the countries that moved. Kenya’s national rate among women 15 to 49 fell from 32 percent in 2003 to 15 percent in 2022. The average hides the map. Mandera and Wajir were still in the mid-to-high 90s in 2022; Samburu and Isiolo barely moved. Women with no education stayed around 56 percent. The Somali ethnic rate fell only from 97 to 86 percent in twenty years. Burkina Faso cut national prevalence from about 76 percent in 2010 to 56 percent in 2021, and among 15-to-19-year-olds from 58 percent to 32 percent. That is one of the cleanest cohort shifts on the continent, and it sits next to a 1996 criminal law that the state has actually used — including mobile hearings in rural districts. Senegal’s 15-to-19 rate went from 25 percent in 2005 to 16 percent in 2023, with the old high-prevalence regions in the south and east still well above 60 percent. Uganda, never a high-prevalence country, is treated by the Joint Programme as on track to eliminate FGM nationally by 2030. New 2025 data are cited for Eritrea as also on that path.

Did the programmes work?

The honest answer is: some of them, in some places, on some outcomes, far too slowly for the 2030 target.

Girls aged 15 to 19 in the countries with data are about one-third less likely to have been cut than their mothers’ generation was thirty years ago. East Africa saw the steepest drop among children 0 to 14 in the Kandala analyses; West Africa slower; a handful of states — Guinea, Mali, Gambia in several trend papers — essentially flat. The UNFPA–UNICEF Joint Programme, running since 2008 in 18 countries, is the largest coordinated effort. Its 2025 report is both a results sheet and a warning. In that year the programme recorded more than 7.5 million people in community dialogues, 4.3 million public declarations of abandonment, 2.2 million girls and women reached with prevention and protection services, 560,000 receiving FGM-related health care, 313 million reached by mass media, 932 arrests and 711 court cases. Guinea and Djibouti wrote an explicit constitutional prohibition. Donor commitments to the same programme fell 455 percent in 2025. The report’s own arithmetic is that meeting SDG 5.3 would take a 27-fold acceleration of the current elimination trend.

That is the difference between activity and incidence. Declarations and radio spots are intermediate outcomes. A girl not being cut is the endpoint, and it is measured years later in a DHS cluster. Matanda and colleagues’ 2023 review of interventions from 2008 to 2020, and UNICEF’s later “what works” synthesis, are more useful than anniversary press releases. They sort the toolkit into three piles.

What has supporting evidence across more than one country:

  • Formal schooling for girls, and maternal education. The effect is slow. It is also one of the few individual-level findings that repeats.

  • Health education that names complications in local language, aimed at women, men and adolescents, not only at “awareness.”

  • Community dialogue that includes parents and religious leaders, not only women’s groups talking to themselves.

  • Media and social-marketing campaigns that shift what people think their neighbours will tolerate.

  • Training health workers to refuse to cut and to treat complications, including deinfibulation.

What is promising but incomplete: legislation plus political will plus local enforcement — Burkina Faso is the exhibit. Law alone, in a district where every grandmother still expects the cut, drives the practice into kitchens and across a border.

What has been tested and does not end the practice:

  • Paying or “converting” traditional cutters and offering them alternative incomes. The demand remains; a new cutter appears.

  • Standalone “alternative rites of passage” that keep the public ceremony and drop the cutting. Families often do both: the ceremony and, quietly, the blade.

The reviews are blunt about a second gap. Community work changes attitudes more reliably than it changes behaviour. A mother can tell a survey-taker that FGM should stop and still take her daughter to a midwife the week before a wedding. Measuring declarations as if they were abandoned cuts is how programmes look successful on the year they are funded and unfinished on the year the next DHS lands.

Why families still do it

The drivers are not mysterious and they are not primarily religious doctrine, even when they are dressed as such. Al-Azhar in Egypt and networks of Muslim women scholars in Indonesia have been pulled into Joint Programme work precisely because the fiqh argument is contestable. The durable reasons are social: marriageability, proof of virginity, control of female sexual behaviour, a girl’s membership in her ethnic group, the fear that an uncut daughter will be unmarriageable and a family will lose bridewealth and standing. In Sierra Leone the Bondo society still organises the rite. In Somali counties of Kenya the practice tracks clan far more than it tracks the national statute. Poverty and missing girls’ secondary school keep the arrangement in place. Urban, educated, wealthier households cut less in most surveys. That gradient is not automatic protection. It is a description of who has already left the norm.

A newer driver is the clinic. Medicalization rose because parents wanted less blood and because some providers from practising communities believed a sterile cut was the responsible compromise. UNFPA’s latest FAQ notes that among girls who have been cut, a growing share — and a higher share of adolescents than of older women — were cut by a health worker. Sudan and Egypt lead. Guinea, Kenya and Nigeria appear in the second tier. A medicalized cut still removes healthy tissue. It still raises obstetric risk. It makes prosecution harder, because the perpetrator has a licence.

What a gynaecology service is for

Prevention is a public-health and legal problem. The woman already cut is a clinical one. WHO’s April 2025 guideline is the current reference for the second task. Deinfibulation is recommended to prevent and treat obstetric complications in Type III. Timing can be antenatal or in labour; the point is that it is a planned procedure with counselling, not an emergency improvisation. Mental-health care is indicated when anxiety, depression or PTSD are present — which, after childhood cutting, they often are. Sexual-function interventions, surgical and non-surgical, belong in the same service line as fistula care, not in a side room labelled “culture.”

For a hospital seeing African and diaspora patients, three operational facts matter.

  • Ask. A normal-looking introitus does not rule out Type I or a partial Type II. Type III is obvious. The history is not.

  • Do not re-infibulate after delivery. Families will ask. The professional codes WHO wants in place exist to give the midwife an answer that is not a private moral struggle.

  • A girl booked as a child visitor from a high-prevalence district in the school holidays is a safeguarding case, not a cultural courtesy.

The 2030 elimination target will be missed on current trends. That sentence is now in the Joint Programme’s own report. It does not mean the last thirty years were wasted. Burkina Faso’s teenagers, Kenya’s national curve, Uganda’s near-zero rate, and the Gambia vote that refused to legalise the blade again are the evidence that the practice moves when law, school, clinic and neighbourhood argument run at the same time. It does not move when a project pays the cutter, prints a T-shirt, and leaves.

Sources

  • WHO fact sheet, Female genital mutilation (updated 2025); WHO guideline on the prevention of FGM and clinical management of complications (28 April 2025); WHO estimate of US$1.4 billion annual treatment cost.

  • UNICEF global databases and country FGM profiles (compiled 2025–2026 from DHS/MICS); UNICEF, A Profile of Female Genital Mutilation in Eastern and Southern Africa (2025); UNICEF estimate of 230 million survivors, ~144 million in Africa.

  • UNFPA FGM FAQ; UNFPA–UNICEF Joint Programme annual reports 2024 and 2025 (“The Race to 2030”); 2025 country snapshots for Burkina Faso, Senegal, Uganda.

  • Matanda et al., PLOS Global Public Health (2023), review of FGM interventions 2008–2020; UNICEF evidence briefs and 2025 “What Works” synthesis; Koski and Heymann, BMJ Global Health (2017), 30-year trends in 22 countries; Kandala et al. on child-prevalence decline.

  • Population Council analysis of Kenya DHS 2003–2022; FGM/C Research Initiative Burkina Faso data update 2024; Reuters/Guardian/JURIST reporting on the Gambia parliamentary vote, July 2024.

  • African Committee of Experts on the Rights and Welfare of the Child, thematic report on harmful practices (2026), on Somali state-level laws 2024–2025.

g

Published by

gynecology.hospital Editorial Team

Editorial briefinggynecology.hospital

Research briefings by the gynecology.hospital editorial team summarise published studies and official data, and list their sources at the end of each article.

More in this category